Voyager Therapeutics (VYGR) Insider Trading & Ownership $5.15 -0.13 (-2.46%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$5.23 +0.08 (+1.57%) As of 04:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Voyager Therapeutics (NASDAQ:VYGR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.39%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$132.53K Get VYGR Insider Trade Alerts Want to know when executives and insiders are buying or selling Voyager Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VYGR Insider Buying and Selling by Quarter Voyager Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/3/2025Nathan D JorgensenCFOSell7,666$4.78$36,643.48 4/2/2025Alfred SandrockCEOSell10,885$3.43$37,335.55 1/14/2025Robin SwartzCOOSell3,087$5.09$15,712.83 1/14/2025Todd Alfred CarterInsiderSell1,191$5.13$6,109.83 12/23/2024Robin SwartzCOOSell6,500$5.65$36,725.00 (Data available from 1/1/2013 forward) VYGR Insider Trading Activity - Frequently Asked Questions Who is on Voyager Therapeutics' Insider Roster? The list of insiders at Voyager Therapeutics includes Alfred Sandrock, Ecor1 Capital, Llc, Nathan D Jorgensen, Neurocrine Biosciences Inc, Peter P Pfreundschuh, Robert W Hesslein, Robin Swartz, Rock Ventures Iii L.P. Third, Sandell Jacquelyn Fahey, and Todd Alfred Carter. Learn more on insiders at VYGR. What percentage of Voyager Therapeutics stock is owned by insiders? 6.39% of Voyager Therapeutics stock is owned by insiders. Learn more on VYGR's insider holdings. Which Voyager Therapeutics insiders have been selling company stock? The following insiders have sold VYGR shares in the last 24 months: Alfred Sandrock ($37,335.55), Nathan D Jorgensen ($36,643.48), Robin Swartz ($70,620.28), Sandell Jacquelyn Fahey ($34,914.18), and Todd Alfred Carter ($15,199.71). How much insider selling is happening at Voyager Therapeutics? Insiders have sold a total of 39,137 Voyager Therapeutics shares in the last 24 months for a total of $194,713.20 sold. Voyager Therapeutics Key ExecutivesDr. Alfred W. Sandrock Jr. (Age 66)M.D., Ph.D., President, CEO & Director Compensation: $1.01MMs. Robin Swartz (Age 53)COO, Principal Financial & Accounting Officer and Acting Chief Business Officer Compensation: $661.98kMs. Jacquelyn Fahey Sandell Esq. (Age 53)J.D., Chief Legal Officer Compensation: $538.16kDr. Krystof Bankiewicz M.D.Ph.D., FounderDr. Guangping Gao Ph.D.Founder & Member of Scientific Advisory BoardDr. Mark A. Kay M.D. (Age 65)Ph.D., Founder Dr. Phillip D. Zamore Ph.D.Founder & Member of Scientific Advisory BoardMr. Todd Carter Ph.D. (Age 54)Chief Scientific Officer Ms. Michelle Quinn SmithChief Human Resources OfficerDr. Maria Lopez-Bresnahan M.B.A.M.D., Senior Vice President of Translational Medicine & Clinical Development More Insider Trading Tools from MarketBeat Related Companies Praxis Precision Medicines Insider Selling Collegium Pharmaceutical Insider Selling Upstream Bio Insider Selling ARS Pharmaceuticals Insider Selling Rapport Therapeutics Insider Selling Spyre Therapeutics Insider Selling Sana Biotechnology Insider Selling Bicara Therapeutics Insider Selling Cronos Group Insider Selling Relay Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:VYGR) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredElon callingElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
